X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/858788/mindbio-therapeutics-scientists-present-landmark-womens-health-trials-company-to-release-phase-2a-depression-trial-secondary-data-this-month
https://www.accesswire.com/858417/mindbio-is-exploring-dual-listing-on-a-senior-exchange-with-multiple-phase-2b-clinical-trials-underway-supported-by-positive-trial-data-and-planning-for-phase-3
https://www.accesswire.com/858054/mindbio-therapeutics-announces-landmark-womens-health-cns-drug-trials
https://www.accesswire.com/855668/mindbio-landmark-sleep-research-published-in-prestigious-nature-portfolio-journal-translational-psychiatry
https://www.accesswire.com/853473/lender-requests-to-convert-loan-to-mindbio-shares
https://www.accesswire.com/838825/mindbio-therapeutics-receives-final-regulatory-approval-to-conduct-phase-2b-randomised-controlled-trial-microdosing-mb22001-in-patients-diagnosed-with-major-depressive-disorder
Market Place
Share 
